Reporting owner · CIK 0001980648

Lee Chan Henry

SEC Form 4 history for the last 180 days across 1 company, 3 transactions and 2 filings.

SVP, GCSVP, General CounselBeOne Medicines Ltd.
Open-market transaction mix0% buys0 buys · 3 sales

Period: Last 180 days

Trade dates in this period: Sep 30, 2026 – Nov 5, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings2Form 4 records
Buying$00 purchases
Selling—3 sales
Net value—Buys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Lee Chan Henry transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
ONCBeOne Medicines Ltd.
Senior Vice President · General Counsel
SVP, GC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
—View disclosure →
ONCBeOne Medicines Ltd.
Senior Vice President · General Counsel
SVP, GC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
—View disclosure →
ONCBeOne Medicines Ltd.
Senior Vice President · General Counsel
SVP, GC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$418kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at BeOne Medicines Ltd. on Nov 5, 2026 with an unknown reported value.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 202601$0$418,125−$418,125
Nov 202602$0——

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size—
Median P/S size—
Direct3
Indirect0
Nov 5, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

3 observations · Sep 30, 2026 – Nov 5, 2026. Window ends at the latest available report, not today.

Selected observation · Nov 5, 20260 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 30, 20260Oct 2, 2026View transaction
Nov 5, 2026455Nov 9, 2026View transaction
Nov 5, 20260Nov 9, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Lee Chan Henry Insider Activity FAQ

SEC Form 4 context

Who is Lee Chan Henry?

Lee Chan Henry is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001980648.

Which companies has Lee Chan Henry reported transactions for?

BeOne Medicines Ltd., BeiGene, Ltd.

When was Lee Chan Henry's latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was Lee Chan Henry's latest insider sale?

The insider reported a sale at BeOne Medicines Ltd. on Nov 5, 2026 with an unknown reported value.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.